Amplify Weight Loss Drug & Treatment ETF (THNR) Holdings List

$24.21 +0.18 (+0.77%)

As of 02:50 PM Eastern

What stocks does THNR hold?

The Amplify Weight Loss Drug & Treatment ETF (THNR) has 22 holdings, with Eli Lilly and Company, Novo Nordisk A/S, and CSPC Pharmaceutical Group Limited among its largest positions. The top 23 THNR holdings ordered by weight make up 99.99% of the total fund. THNR is an equity fund in the strategy category that invests in publicly traded companies and other investments, focused on theme strategies within the Global region. This page includes a complete THNR stock holdings list ranked by weight, along with a full breakdown of sector, geographic, industry, and currency exposure.

Top 23 THNR Holdings

Rank	Company	Current Price	Weight	Shares Held
1	LLY Eli Lilly and Company	$1,214.15 +4.1%	10.20%	503
2	NVO Novo Nordisk A/S	$38.19 +0.3%	8.50%	12,835
3	CSPC Pharmaceutical Group Limited	N/A	5.88%	262,000
4	AMGN Amgen	$427.33 +3.5%	5.63%	788
5	PFE Pfizer	$29.38 +3.5%	5.37%	10,896
6	ABBV AbbVie	$285.20 +3.9%	5.36%	1,149
7	Innovent Biologics, Inc.	N/A	5.33%	24,500
8	AstraZeneca PLC	N/A	5.25%	1,888
9	Roche Holding AG	N/A	5.24%	708
10	GILD Gilead Sciences	$153.64 +3.9%	5.20%	2,024
11	MRK Merck & Co., Inc.	$147.62 +4.0%	5.18%	2,025
12	REGN Regeneron Pharmaceuticals	$780.45 +3.6%	4.96%	380
13	VKTX Viking Therapeutics	$25.86 -2.9%	4.84%	9,118
14	Chugai Pharmaceutical Co., Ltd.	N/A	4.75%	7,000
15	ARWR Arrowhead Pharmaceuticals	$58.89 +1.3%	4.03%	3,541
16	Zealand Pharma A/S	N/A	3.94%	5,542
17	Hanmi Pharm. Co., Ltd.	N/A	3.67%	552
18	GPCR Structure Therapeutics	$22.28 -0.1%	2.99%	6,098
19	Jiangsu Hengrui Pharmaceuticals Co.,Ltd	N/A	2.40%	21,400
20	Invesco Shrt-Trm Inv Gov&Agcy Instl	N/A	1.08%	60,718
21	KLRA Kailera Therapeutics	$10.91 +1.3%	0.92%	4,979
22	US DOLLARS	N/A	0.00%	213
23	OTHER ASSETS AND LIABILITIES	N/A	-0.73%	327,558,207

THNR Geographic Exposure

THNR's largest geographic exposure is United States at 64.3%, followed by Hong Kong at 5.5%.

United States
64.3%
Hong Kong
5.5%
United Kingdom
5.3%
Cayman Islands
5.2%
Japan
4.9%
Denmark
3.5%
Korea, Republic of
3.4%

THNR Currency Exposure

THNR's largest currency exposure is USD at 75.2%, followed by HKD at 13.0%.

USD
75.2%
HKD
13.0%
JPY
4.9%
DKK
3.5%
KRW
3.4%

THNR Sector Exposure

THNR's largest sector exposure is Health Care at 90.9%.

Health Care
90.9%

THNR Industry Exposure

THNR's largest industry exposure is Biotechnology at 88.4%, followed by Pharmaceuticals at 2.5%.

Biotechnology
88.4%
Pharmaceuticals
2.5%

THNR Sub-Industry Exposure

THNR's largest sub-industry exposure is Biotechnology at 88.4%, followed by Pharmaceuticals at 2.5%.

Biotechnology
88.4%
Pharmaceuticals
2.5%

Related Companies and Tools

Related Companies

MarketBeat tracks Amplify Weight Loss Drug & Treatment ETF holdings and portfolio composition, last updated on 10/6/2026.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Amplify Weight Loss Drug & Treatment ETF (THNR) Holdings List